Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 21,661-21,672 of 23,847
Drug study icon
CompletedNCT00044187

The Assessment of a Weight-Gain Agent for Olanzapine-Associated Anti-Obesity Agent in people with Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolarity type I

This study is completed in the United States. It focuses on schizophrenia.

Multiple locations, including El Centro
Bipolarity, SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Eli Lilly and Company
Condition
Bipolarity, Schizophrenia
Other study type icon
CompletedNCT07227753

The Association Between Gut Microbiota Diversity and Postpartum Depression

This observational study is following people with Depression During Pregnancy to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In Boston
DepressionOtherOver 18 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Depression
Behavioral study icon
CompletedNCT05247151

The Association of Affective Resonance With Empathy Modulated by Negative Symptomatology and Oxytocin

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

In Berlin
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Germany
Sponsor
Charite University, Berlin, Germany
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.